ARKG
$45.44ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense ratio
0.75%
Dividend yield
0.00%
AUM
$2.02B
Issuer
ARK
YTD return
61.72%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · ARKG
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 9.58% |
| TWST | Twist Bioscience Corp | 9.13% |
| TEM | Tempus AI Inc Class A common stock | 7.91% |
| CRSP | CRISPR Therapeutics AG | 6.10% |
| PSNL | Personalis Inc | 5.93% |
| ABSI | Absci Corp | 4.88% |
| NTRA | Natera Inc | 4.06% |
| ILMN | Illumina Inc | 4.04% |
| LLY | Eli Lilly and Co | 3.86% |
| CDNA | CareDx Inc | 3.85% |
Sector exposure
Sector breakdown · ARKG
Healthcare100.0%